216 related articles for article (PubMed ID: 32558592)
1. Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review.
Zhang L; Valizadeh H; Alipourfard I; Bidares R; Aghebati-Maleki L; Ahmadi M
COPD; 2020 Jun; 17(3):333-342. PubMed ID: 32558592
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD.
Leuenberger C; Schuoler C; Bye H; Mignan C; Rechsteiner T; Hillinger S; Opitz I; Marsland B; Faiz A; Hiemstra PS; Timens W; Camici GG; Kohler M; Huber LC; Brock M
J Mol Med (Berl); 2016 Jun; 94(6):725-34. PubMed ID: 26864305
[TBL] [Abstract][Full Text] [Related]
3. Curcumin modulates the effect of histone modification on the expression of chemokines by type II alveolar epithelial cells in a rat COPD model.
Gan L; Li C; Wang J; Guo X
Int J Chron Obstruct Pulmon Dis; 2016; 11():2765-2773. PubMed ID: 27853364
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.
Sundar IK; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1245-L1258. PubMed ID: 27793800
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of airway inflammation.
Adcock IM; Tsaprouni L; Bhavsar P; Ito K
Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
[TBL] [Abstract][Full Text] [Related]
6. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD.
Rajendrasozhan S; Yao H; Rahman I
COPD; 2009 Aug; 6(4):291-7. PubMed ID: 19811389
[TBL] [Abstract][Full Text] [Related]
7. [Lung cancer and its epigenetics association with chronic obstructive pulmonary disease].
Xu PW; Jin YT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):70-3. PubMed ID: 23450484
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms in chronic obstructive pulmonary disease.
Zong DD; Ouyang RY; Chen P
Eur Rev Med Pharmacol Sci; 2015; 19(5):844-56. PubMed ID: 25807439
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases.
Sundar IK; Yao H; Rahman I
Antioxid Redox Signal; 2013 May; 18(15):1956-71. PubMed ID: 22978694
[TBL] [Abstract][Full Text] [Related]
10. Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD.
Yao H; Rahman I
Am J Physiol Lung Cell Mol Physiol; 2012 Oct; 303(7):L557-66. PubMed ID: 22842217
[TBL] [Abstract][Full Text] [Related]
11. Targeting transcription factor lysine acetylation in inflammatory airway diseases.
van den Bosch T; Kwiatkowski M; Bischoff R; Dekker FJ
Epigenomics; 2017 Jul; 9(7):1013-1028. PubMed ID: 28617138
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms in COPD: implications for pathogenesis and drug discovery.
Schamberger AC; Mise N; Meiners S; Eickelberg O
Expert Opin Drug Discov; 2014 Jun; 9(6):609-28. PubMed ID: 24850530
[TBL] [Abstract][Full Text] [Related]
13. The potential for targeted rewriting of epigenetic marks in COPD as a new therapeutic approach.
Wu DD; Song J; Bartel S; Krauss-Etschmann S; Rots MG; Hylkema MN
Pharmacol Ther; 2018 Feb; 182():1-14. PubMed ID: 28830839
[TBL] [Abstract][Full Text] [Related]
14. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease.
Barnes PJ
Proc Am Thorac Soc; 2009 Dec; 6(8):693-6. PubMed ID: 20008877
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction.
Barreiro E; Sznajder JI
J Appl Physiol (1985); 2013 May; 114(9):1263-72. PubMed ID: 23305984
[TBL] [Abstract][Full Text] [Related]
16. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?
Puig-Vilanova E; Ausin P; Martinez-Llorens J; Gea J; Barreiro E
PLoS One; 2014; 9(7):e102296. PubMed ID: 25013984
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease.
Barreiro E; Gea J
Transl Res; 2015 Jan; 165(1):61-73. PubMed ID: 24794953
[TBL] [Abstract][Full Text] [Related]
18. Targeting epigenetic DNA and histone modifications to treat kidney disease.
Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
[TBL] [Abstract][Full Text] [Related]
19. Are There Any Epigenetic Similarities Between Treatment Unresponsive Sarcoidosis, COPD and Severe Asthma?
Mortaz E; Eslaminejad A; Varahram M; Heshmatnia J; Abedini A; Kiani A; Velayati A; Garssen J; Adcock IM
Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):472-5. PubMed ID: 26742435
[No Abstract] [Full Text] [Related]
20. Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics.
Sundar IK; Mullapudi N; Yao H; Spivack SD; Rahman I
Curr Opin Pulm Med; 2011 Jul; 17(4):279-85. PubMed ID: 21537190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
